Your session is about to expire
← Back to Search
Intraocular Lens
Clareon® monofocal Intraocular lens (toric and non-toric models) for Pseudoaphakia
N/A
Waitlist Available
Led By Joesph Christenbury, MD
Research Sponsored by Eye Consultants of Atlanta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months postoperative
Awards & highlights
No Placebo-Only Group
Summary
To evaluate visual outcomes, in-the-bag placement and patient satisfaction in patients implanted with either Clareon monofocal or Clareon monofocal toric IOLs with the Monarch IV inserter and targeted for emmetropia.
Eligible Conditions
- Pseudoaphakia
- Cataract
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months postoperative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months postoperative
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Consistency of in-the-bag delivery of IOL during implantation with Monarch IV
Manifest refraction
Overall surgeon satisfaction of Monarch IV delivery experience
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Clareon® monofocal Intraocular lens (toric and non-toric models)Experimental Treatment1 Intervention
Bilateral implantation of the Clareon monofocal Intraocular lens (toric and non-toric models) with the Monarch IV inserter
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Clareon monofocal Intraocular lens (toric and non-toric models)
2022
N/A
~40
Find a Location
Who is running the clinical trial?
SengiUNKNOWN
25 Previous Clinical Trials
2,064 Total Patients Enrolled
Eye Consultants of AtlantaLead Sponsor
Joesph Christenbury, MDPrincipal InvestigatorEye Consultants of Atlanta
Share this study with friends
Copy Link
Messenger